MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2016-08-25 for PERFLUORON manufactured by Alcon Laboratories, Inc..
[52949070]
No data regarding product identity were indicated for the event; therefore, the device history record (dhr) could not be reviewed. No sample was returned; therefore, the condition of the product could not be verified. Because a sample was not returned and no lot number was indicated for this complaint, the root cause cannot be determined. The directions for use (dfu) for this product states: pfo must be completely removed at the conclusion of the procedure by aspiration through either a 23 gauge or flute needle during the air-fluid exchange, or by direct exchange with an appropriate long-term vitreous substitute. Failure to remove may result in visual abnormalities and secondary surgical intervention. (b)(4).
Patient Sequence No: 1, Text Type: N, H10
[52949071]
In a literature article information was presented with regard to a retrospective study of a cluster of six cases of retained intraocular perfluoron (pfo) that occurred after pars plana vitrectomy (ppv) for retinal detachment repair. Pfo was noted in the anterior chamber (ac) and/or vitreous and removed with ac paracentesis, ac wash-out, and/or ppv. These cases were noted shortly after the facility transitioned from non-valved trocar cannulas to valved trocar cannulas between may 16, 2012 through january 7, 2013. This is the fourth of six reports. Reference: oellers p, schneider e, fekrat s, mahmoud t, mruthyunjaya p, hahn p. Retained intraocular perfluoro-n-octane after valved cannula pars plana vitrectomy for retinal detachment. Ophthalmic surg lasers imaging retina. 2015; 46: 451-456.
Patient Sequence No: 1, Text Type: D, B5
Report Number | 1610287-2016-00093 |
MDR Report Key | 5903084 |
Report Source | COMPANY REPRESENTATIVE,HEALTH |
Date Received | 2016-08-25 |
Date of Report | 2016-08-24 |
Date Mfgr Received | 2016-07-28 |
Date Added to Maude | 2016-08-25 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Manufacturer Contact | MS. RITA LOPEZ |
Manufacturer Street | 6201 SOUTH FREEWAY MAIL STOP AB2-6 |
Manufacturer City | FORT WORTH TX 76134 |
Manufacturer Country | US |
Manufacturer Postal | 76134 |
Manufacturer Phone | 8175514846 |
Manufacturer G1 | ALCON LABORATORIES, INC. |
Manufacturer Street | 6201 SOUTH FREEWAY |
Manufacturer City | FORT WORTH TX 76134 |
Manufacturer Country | US |
Manufacturer Postal Code | 76134 |
Single Use | 3 |
Previous Use Code | 3 |
Removal Correction Number | NA |
Event Type | 3 |
Type of Report | 3 |
Brand Name | PERFLUORON |
Generic Name | FLUID, INTRAOCULAR |
Product Code | LWL |
Date Received | 2016-08-25 |
Model Number | NA |
Catalog Number | ASKU |
Lot Number | ASKU |
Operator | HEALTH PROFESSIONAL |
Device Availability | N |
Device Eval'ed by Mfgr | R |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | ALCON LABORATORIES, INC. |
Manufacturer Address | 6201 SOUTH FREEWAY FORT WORTH TX 76134 US 76134 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Required No Informationntervention | 2016-08-25 |